EVAX (EVAX) Stock Price & Analysis
EVAX (EVAX) rose 4.17% to USD 3.25 as of September 8, 2026 at 14:51 UTC, according to Nexqual real-time market data.
EVAX last closed at USD 3.25; the session ranged USD 3.12–3.31 on volume of 34,269 shares. Market capitalization is —, with a 52-week range of USD 2.71–12.15 (NCM). Source: Nexqual, September 8, 2026 at 14:51 UTC.
Key Statistics (as of September 8, 2026 at 14:51 UTC)
| Price | USD 3.25 |
|---|---|
| Change | ▲ 4.17% (up) |
| Previous Close | USD 3.25 |
| Open | USD 3.25 |
| Day Range | USD 3.12 – 3.31 |
| 52-Week Range | USD 2.71 – 12.15 |
| Volume | 34,269 shares |
| Market Cap | — |
| Exchange | NCM |
Technical Analysis (EVAX)
Nexqual's technical model rates EVAX "STRONG BUY" based on 5 bullish and 0 bearish signals across 127 daily candles, as of September 8, 2026 at 14:51 UTC.
| Overall Signal | STRONG BUY |
|---|---|
| RSI (14) | 56.93 (neutral) |
| vs SMA50 | Above (USD 3.1) |
| MACD | 0 (positive) |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| ABVC | ABVC Biopharma, Inc. | USD 0.99 | ▼ 1.01% |
| RNXT | RenovoRx, Inc. | USD 2.2 | ▼ 7.38% |
| RNAZ | TransCode Therapeutics, Inc. | USD 2 | ▼ 7.19% |
| ENSC | Ensysce Biosciences, Inc. | USD 0.44 | ▼ 0.57% |
| BBLG | Bone Biologics Corp | USD 0.58 | ▲ 3.41% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 14:51 UTC. This page is informational and not investment advice.